Oxaliplatin/5FU/LV in adjuvant colon cancer: Updated efficacy results of the MOSAIC trial, including survival, with a median follow-up of six years

Reviewer: Christopher Dolinsky, MD
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 5 de junio del 2007

Translation for this article does not exist

Keywords

Click on any of these terms for more related articles

Blogs

The Power of a Cancer Support Group
by Bob Riter
May 26, 2016